Daptomycin is an acidic, 13-amino acid, cyclic polypeptide that contains
a number of non-proteinogenic residues and is modified at its N-terminus with a
decanoyl chain. It has been in clinical use since 2003 against selected
drug-resistant Staphylococcus aureus and Enterococcus
spp infections. In vitro, daptomycin is active against
Gram-positive pathogens at low concentrations but its antibiotic activity
depends critically on the presence of calcium ions. This dependence has been
thought to arise from binding of one or two Ca2+ ions to
daptomycin as a required step in its interaction with the bacterial membrane.
Here, we investigated the interaction of daptomycin with giant unilamellar
vesicles (GUVs) composed 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) and
1-palmitoyl-2-oleoylphosphatidylglycerol (POPG). We used fluorescence confocal
microscopy to monitor binding of the peptide to GUVs and follow its effect on
the membrane of the vesicle. We found that, in the absence of POPG or
Ca2+, daptomycin does not bind measurably to the lipid
membrane. In the presence of 20–30% PG in the membrane and 2 mM
Ca2+, daptomycin induces the formation of membrane
domains rich in acidic lipids. This effect is not induced by
Ca2+ alone. In addition, daptomycin causes GUV collapse,
but it does not translocate across the membrane to the inside of intact
POPC:POPG vesicles. We conclude that pore formation is probably not the
mechanism by which the peptide functions. On the other hand, we found that
daptomycin coclusters with the anionic phospholipid POPG and the fluorescent
probes used, leading to extensive formation of daptomycin–POPG domains
in the membrane.